Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhixue Quyu Mingmu Tablet for fundus hemorrhage in wet age-related macular degeneration after ranibizumab
ChiCTR-TRC-14004562Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2013
- Countries
- 1
01
Overview
Phase 4 trial of zhixue quyu mingmu in age-related macular degeneration (AMD) and retinal hemorrhage (RH) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Change in ETDRS letter score within 6 months. Started Dec 2013; status: completed.
02
Drugs
zhixue quyu mingmu
03
Conditions
age-related macular degeneration (AMD)retinal hemorrhage (RH)
Beyond the preview
Go deeper on ChiCTR-TRC-14004562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004562.